Moderna said that it had asked the Food and Drug Administration to authorize its coronavirus vaccine for children under 6, making it the first manufacturer to do so. A top official at the company said it would finish submitting data to regulators by May 9.
The development, which was expected, steps up pressure on federal regulators to authorize a vaccine for the nation’s youngest children. Parents of the roughly 18 million youngest Americans, the only population group not yet eligible for vaccination, have been increasingly vocal about their frustration with delays, and members of Congress have been asking the F.D.A. why it can’t move faster.
Source: NY Times
